Cargando…

Corrigendum: Development of a phagocytosis- dependent gene signature to predict prognosis and response to checkpoint inhibition in clear-cell renal cell carcinoma

Detalles Bibliográficos
Autores principales:	Li, Kunping, Li, Yuqing, Lyu, Yinfeng, Tan, Linyi, Zheng, Xinyi, Jiang, Haowen, Wen, Hui, Feng, Chenchen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893484/ https://www.ncbi.nlm.nih.gov/pubmed/36742313 http://dx.doi.org/10.3389/fimmu.2023.1140764

Ejemplares similares

Development of a Phagocytosis-Dependent Gene Signature to Predict Prognosis and Response to Checkpoint Inhibition in Clear-Cell Renal Cell Carcinoma
por: Li, Kunping, et al.
Publicado: (2022)

PFKFB4 is overexpressed in clear-cell renal cell carcinoma promoting pentose phosphate pathway that mediates Sunitinib resistance
por: Feng, Chenchen, et al.
Publicado: (2021)

Correction to: PFKFB4 is overexpressed in clear-cell renal cell carcinoma promoting pentose phosphate pathway that mediates Sunitinib resistance
por: Feng, Chenchen, et al.
Publicado: (2021)

BCL2L2 loss renders ‐14q renal cancer dependent on BCL2L1 that mediates resistance to tyrosine kinase inhibitors
por: Lyu, Yinfeng, et al.
Publicado: (2021)

Correction to: BCL2L2 loss renders ‐14q renal cancer dependent on BCL2L1 that mediates resistance to tyrosine kinase inhibitors
por: Lyu, Yinfeng, et al.
Publicado: (2023)

Association between copy-number alteration of +20q, −14q and −18p and cross-sensitivity to tyrosine kinase inhibitors in clear-cell renal cell carcinoma
por: Wang, Liang, et al.
Publicado: (2020)

ASXL1 promotes adrenocortical carcinoma and is associated with chemoresistance to EDP regimen
por: Wang, Liang, et al.
Publicado: (2021)

Correction for: ASXL1 promotes adrenocortical carcinoma and is associated with chemoresistance to EDP regimen
por: Wang, Liang, et al.
Publicado: (2023)

Overexpression of steroid sulfotransferase genes is associated with worsened prognosis and with immune exclusion in clear cell-renal cell carcinoma
por: Li, Yuqing, et al.
Publicado: (2019)

Comprehensive assessment gene signatures for clear cell renal cell carcinoma prognosis
por: Chang, Peng, et al.
Publicado: (2018)

Prognosis, Immune Microenvironment Infiltration and Immunotherapy Response in Clear Cell Renal Cell Carcinoma Based on Cuproptosis-related Immune Checkpoint Gene Signature
por: Liu, Gang, et al.
Publicado: (2023)

An Aging and Senescence-Related Gene Signature for Prognosis Prediction in Clear Cell Renal Cell Carcinoma
por: Li, Jiaying, et al.
Publicado: (2022)

Identification of a 5-Gene Signature Predicting Progression and Prognosis of Clear Cell Renal Cell Carcinoma
por: Pan, Qiufeng, et al.
Publicado: (2019)

Construction of the metabolic reprogramming-associated gene signature for clear cell renal cell carcinoma prognosis prediction
por: Tai, Rongfen, et al.
Publicado: (2023)

Identification of the Prognosis Value and Potential Mechanism of Immune Checkpoints in Renal Clear Cell Carcinoma Microenvironment
por: Liao, Guodong, et al.
Publicado: (2021)

Identification of a 4-microRNA Signature for Clear Cell Renal Cell Carcinoma Metastasis and Prognosis
por: Wu, Xiwei, et al.
Publicado: (2012)

An inflammation-related signature could predict the prognosis of patients with kidney renal clear cell carcinoma
por: Yu, Qingxin, et al.
Publicado: (2022)

Identification of an immune-related risk signature for predicting prognosis in clear cell renal cell carcinoma
por: Hua, Xiaoliang, et al.
Publicado: (2020)

Therapeutic Potential of Natural Products in the Treatment of Renal Cell Carcinoma: A Review
por: Feng, Chenchen, et al.
Publicado: (2022)

A radiogenomics biomarker based on immunological heterogeneity for non-invasive prognosis of renal clear cell carcinoma
por: Gao, Jiahao, et al.
Publicado: (2022)

Dead cell phagocytosis and innate immune checkpoint
por: Yoon, Kyoung Wan
Publicado: (2017)

A novel gene signature related to oxidative stress predicts the prognosis in clear cell renal cell carcinoma
por: Ma, Sheng, et al.
Publicado: (2023)

Identification and validation of a genetic risk signature associated with prognosis in clear-cell renal cell carcinoma patients
por: Lian, Meiqin, et al.
Publicado: (2023)

A Prognostic Signature for Clear Cell Renal Cell Carcinoma Based on Ferroptosis-Related lncRNAs and Immune Checkpoints
por: Dong, Yunze, et al.
Publicado: (2022)

Identification of Prognostic and Metastatic Alternative Splicing Signatures in Kidney Renal Clear Cell Carcinoma
por: Meng, Tong, et al.
Publicado: (2019)

The cuproptosis related genes signature predicts the prognosis and correlates with the immune status of clear cell renal cell carcinoma
por: Sun, Peng, et al.
Publicado: (2022)

Development and validation of ferroptosis-related lncRNAs prognosis signatures in kidney renal clear cell carcinoma
por: Xing, Xiao-Liang, et al.
Publicado: (2021)

A pyroptosis-associated signature plays a role in prognosis prediction in clear cell renal cell carcinoma
por: Li, Zhiyuan, et al.
Publicado: (2022)

A Two-DNA Methylation Signature to Improve Prognosis Prediction of Clear Cell Renal Cell Carcinoma
por: Shi, Shanping, et al.
Publicado: (2019)

A Metastasis-Related lncRNA Signature Correlates With the Prognosis in Clear Cell Renal Cell Carcinoma
por: Dou, Qian, et al.
Publicado: (2021)

Machine learning-based prognosis signature for survival prediction of patients with clear cell renal cell carcinoma
por: Chen, Siteng, et al.
Publicado: (2022)

Deciphering the Role of Melatonin-Related Signatures in Tumor Immunity and the Prognosis of Clear Cell Renal Cell Carcinoma
por: Jiang, Aimin, et al.
Publicado: (2023)

Solute carrier-related signature for assessing prognosis and immunity in patients with clear-cell renal cell carcinoma
por: BAO, WEI, et al.
Publicado: (2023)

Identification of immunogenic cell death-related signature on prognosis and immunotherapy in kidney renal clear cell carcinoma
por: Jiang, Silin, et al.
Publicado: (2023)

Anoikis-related genes signature development for clear cell renal cell carcinoma prognosis and tumor microenvironment
por: Jiang, Yinglei, et al.
Publicado: (2023)

CT-Based Radiomics Signature for Preoperative Prediction of Coagulative Necrosis in Clear Cell Renal Cell Carcinoma
por: Xu, Kai, et al.
Publicado: (2020)

Antioxidant Gene Signature Impacts the Immune Infiltration and Predicts the Prognosis of Kidney Renal Clear Cell Carcinoma
por: Ren, Xueting, et al.
Publicado: (2021)

Corrigendum: Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma
por: Yao, Yicong, et al.
Publicado: (2021)

A Five-Gene Signature Predicts Prognosis in Patients with Kidney Renal Clear Cell Carcinoma
por: Zhan, Yueping, et al.
Publicado: (2015)

Gene Signature Associated With Bromodomain Genes Predicts the Prognosis of Kidney Renal Clear Cell Carcinoma
por: Lu, Junwan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oc0ulmn9e6abti9115ni24pvoo